Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Ubiquinone (coenzyme Q10) prevents renal mitochondrial dysfunction in an experimental model of type 2 diabetes.

Sourris KC, Harcourt BE, Tang PH, Morley AL, Huynh K, Penfold SA, Coughlan MT, Cooper ME, Nguyen TV, Ritchie RH, Forbes JM.

Free Radic Biol Med. 2012 Feb 1;52(3):716-23. doi: 10.1016/j.freeradbiomed.2011.11.017. Epub 2011 Nov 21.

PMID:
22172526
2.

Bioenergetic and antioxidant properties of coenzyme Q10: recent developments.

Littarru GP, Tiano L.

Mol Biotechnol. 2007 Sep;37(1):31-7. Review.

PMID:
17914161
3.

Treatment of diabetic nephropathy with angiotensin II receptor antagonist.

Lewis EJ, Lewis JB.

Clin Exp Nephrol. 2003 Mar;7(1):1-8. Review.

PMID:
14586737
4.

Use of genetic mouse models in the study of diabetic nephropathy.

Allen TJ, Cooper ME, Lan HY.

Curr Atheroscler Rep. 2004 May;6(3):197-202. Review.

PMID:
15068744
5.

Albuminuria: a target for treatment of type 2 diabetic nephropathy.

de Zeeuw D.

Semin Nephrol. 2007 Mar;27(2):172-81. Review.

PMID:
17418686
6.

Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies.

Ozaltin F.

Pediatr Nephrol. 2014 Jun;29(6):961-9. doi: 10.1007/s00467-013-2482-z. Epub 2013 Jun 5. Review.

PMID:
23736673
7.

Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10.

Gueven N, Woolley K, Smith J.

Redox Biol. 2015;4:289-95. doi: 10.1016/j.redox.2015.01.009. Epub 2015 Jan 14. Review.

8.
9.

Clinical applications of coenzyme Q10.

Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Vega AF, de la Mata M, Pavon AD, Alcocer-Gomez E, Calero CP, Paz MV, Alanis M, de Lavera I, Cotan D, Sanchez-Alcazar JA.

Front Biosci (Landmark Ed). 2014 Jan 1;19:619-33. Review.

PMID:
24389208
10.

Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation.

Potgieter M, Pretorius E, Pepper MS.

Nutr Rev. 2013 Mar;71(3):180-8. doi: 10.1111/nure.12011. Epub 2013 Jan 30. Review.

PMID:
23452285
11.

Coenzyme Q10 as a therapy for mitochondrial disease.

Hargreaves IP.

Int J Biochem Cell Biol. 2014 Apr;49:105-11. doi: 10.1016/j.biocel.2014.01.020. Epub 2014 Feb 2. Review.

PMID:
24495877
12.

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Morris G, Anderson G, Berk M, Maes M.

Mol Neurobiol. 2013 Dec;48(3):883-903. doi: 10.1007/s12035-013-8477-8. Epub 2013 Jun 13. Review.

PMID:
23761046
13.

Oligonol, a low-molecular-weight polyphenol derived from lychee fruit, attenuates gluco-lipotoxicity-mediated renal disorder in type 2 diabetic db/db mice.

Park CH, Noh JS, Fujii H, Roh SS, Song YO, Choi JS, Chung HY, Yokozawa T.

Drug Discov Ther. 2015 Feb;9(1):13-22. doi: 10.5582/ddt.2015.01003. Review.

14.

Co-enzyme Q10 to treat neurological disorders: basic mechanisms, clinical outcomes, and future research direction.

Salama M, Yuan TF, Machado S, Murillo-Rodríguez E, Vega JA, Menéndez-González M, Nardi AE, Arias-Carrión O.

CNS Neurol Disord Drug Targets. 2013 Aug;12(5):641-64. Review.

PMID:
23574157
15.

Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction.

Yang YK, Wang LP, Chen L, Yao XP, Yang KQ, Gao LG, Zhou XL.

Clin Chim Acta. 2015 Oct 23;450:83-9. doi: 10.1016/j.cca.2015.08.002. Epub 2015 Aug 6. Review.

PMID:
26254995
16.

Coenzyme Q10 and Heart Failure: A State-of-the-Art Review.

Sharma A, Fonarow GC, Butler J, Ezekowitz JA, Felker GM.

Circ Heart Fail. 2016 Apr;9(4):e002639. doi: 10.1161/CIRCHEARTFAILURE.115.002639. Review.

PMID:
27012265
17.

Argan oil-contained antioxidants for human mitochondria.

López LC, Cabrera-Vique C, Venegas C, García-Corzo L, Luna-Sánchez M, Acuña-Castroviejo D, Escames G.

Nat Prod Commun. 2013 Jan;8(1):47-50. Review.

PMID:
23472457
18.

Mitochondrial dysfunction in inherited renal disease and acute kidney injury.

Emma F, Montini G, Parikh SM, Salviati L.

Nat Rev Nephrol. 2016 May;12(5):267-80. doi: 10.1038/nrneph.2015.214. Epub 2016 Jan 25. Review.

PMID:
26804019
19.

[Redox therapy in mitochondrial diseases using coenzyme Q10].

Gvozdjáková A, Kucharská J, Gvozdják J.

Bratisl Lek Listy. 1994 Oct;95(10):443-51. Review. Slovak.

PMID:
7882058
20.

Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.

Sivitz WI, Yorek MA.

Antioxid Redox Signal. 2010 Apr;12(4):537-77. doi: 10.1089/ars.2009.2531. Review.

Items per page

Supplemental Content

Write to the Help Desk